Supplementary Files
Keywords
learning
absenteeism
asthma
school performance
psychomotor performance
rhinitis
Abstract
Background: Asthma and rhinitis are the most frequent chronic respiratory diseases. Their high impact is associated with the loss of working days, as well as a decrease in academic performance.
Objective: To assess and compare the impact of rhinitis and asthma as causes of absenteeism and low work performance in a population of children and adults.
Material and method: A cross sectional study was performed in 10 schools of two cities in Colombia. The student population between 6 to 17 years, as well as the faculty staff over 18 were invited to participate. All of the participants filled a questionnaire assessing parameters related to clinical background, and a review of scores in Math and Spanish, curriculum vitae and number of missed day during the last academic period completed was performed.
Results: A total of 1,413 participants were enrolled. The frequency of asthma and/or rhinitis was 36%, there was a greater frequency of absenteeism in the population of children with respiratory symptoms (2.8 vs 1.2 days/year/patient, p<0.01) and there was both a lower academic (failure in 17% vs 9%, p<0.05) and work performance (0.43 vs 0.27, p<0.05) in the symptomatic population. We observed that those patients with good adherence to pharmacologic treatment displayed lower absenteeism and an improved performance.
Conclusion: Both rhinitis and asthma are associated with lower performance in children and adults and absenteeism in the school; however, adequate treatment may improve clinical control and reduce backlash against job performance.
References
Dennis R, Caraballo L, Garcia E, Caballero A, et al. Asthma and other allergic conditions in Colombia: a study in 6 cities. Ann Allergy Asthma Immunol 2004;93:568-574.
Vergara C, Caraballo L. Asthma mortality in Columbia. Ann Allergy Asthma Immunol 1998;80:55-60.
Neffen H, Baena-Cagnani CE, Malka S, Sole D, et al. Asthma mortality in Latin America. J Investig Allergol Clin Immunol 1997;7:249-253.
Eder W, Ege MJ, von Mutius E. The asthma epidemic. N Engl J Med 2006;355:2226-2235.
Anandan C, Nurmatov U, van Schayck O, Sheikh A. Is the prevalence of asthma declining? Systematic review of epidemiological studies. Allergy 2010;65:152-167.
Fasce L, Tosca MA, Baroffio M, Olcese R, Ciprandi G. Atopy in wheezing infants always starts with monosensitization. Allergy Asthma Proc 2007;28:449-453.
Yepes-Núñez JJ, Gómez C, Espinoza Y, Cardona R. [The impact of subcutaneous immunotherapy with Dermatophagoides farinae and Dermatophagoides pteronyssinus on the quality of life of patients with allergic rhinitis and asthma]. Biomedica 2014;34:282-290.
Meltzer EO, Gross GN, Katial R, Storms WW. Allergic rhinitis substantially impacts patient quality of life: findings from the Nasal Allergy Survey Assessing Limitations. J Fam Pract 2012;61(2 Suppl):S5-10.
Jáuregui I, Mullol J, Dávila I, Ferrer M, et al. Allergic rhinitis and school performance. J Investig Allergol Clin Immunol 2009;19(Suppl 1):32-39.
Shedden A. Impact of nasal congestion on quality of life and work productivity in allergic rhinitis: findings from a large online survey. Treat Respir Med 2005;4:439-446.
Caraballo L, Acevedo N. Allergy in the tropics: the impact of cross-reactivity between mites and ascaris. Front Biosci (Elite Ed) 2011;3:51-64.
Sanchez J, Diez S, Cardona R. Sensibilización a aeroalergenos en pacientes alérgicos de Medellín, Colombia. Revista Alergia México 2012;59:139-147.
Riechelmann H, Europäischen Akademie für Allergie und Klinische Immunologie (EAACI) un der European Rhinologic Society (ERS). [Chronic Rhinosinusitis - EPOS 2012 Part I]. Laryngorhinootologie 2013;92:193-201; quiz 2-3.
Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373-383.
Velástegui C, Pérez-Canto P, Zárate V, Arenas D, et al. [Impact of asthma among primary attention children]. Rev Med Chil 2010;138:205-212.
Blanchette CM, Gutierrez B, Ory C, Chang E, Akazawa M. Economic burden in direct costs of concomitant chronic obstructive pulmonary disease and asthma in a Medicare Advantage population. J Manag Care Pharm 2008;14:176-185.
Baiardini I, Braido F, Tarantini F, Porcu A, et al. ARIAsuggested drugs for allergic rhinitis: what impact on quality of life? A GA2LEN review. Allergy 2008;63:660-669.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Copyright (c) 2016 Revista Alergia México